These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35390760)

  • 1. Heart rate variability in obsessive compulsive disorder in comparison to healthy controls and as predictor of treatment response.
    Olbrich H; Jahn I; Stengler K; Seifritz E; Colla M
    Clin Neurophysiol; 2022 Jun; 138():123-131. PubMed ID: 35390760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EEG-arousal regulation as predictor of treatment response in patients suffering from obsessive compulsive disorder.
    Dohrmann AL; Stengler K; Jahn I; Olbrich S
    Clin Neurophysiol; 2017 Oct; 128(10):1906-1914. PubMed ID: 28826021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in obsessive-compulsive disorder patients.
    Kawano A; Tanaka Y; Ishitobi Y; Maruyama Y; Ando T; Inoue A; Okamoto S; Imanaga J; Kanehisa M; Higuma H; Ninomiya T; Tsuru J; Akiyoshi J
    Psychiatry Res; 2013 Aug; 209(1):85-90. PubMed ID: 23266021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional connectivity of the raphe nucleus as a predictor of the response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Kim M; Kwak S; Yoon YB; Kwak YB; Kim T; Cho KIK; Lee TY; Kwon JS
    Neuropsychopharmacology; 2019 Nov; 44(12):2073-2081. PubMed ID: 31189178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-minute recordings of heart rate variability in obsessive-compulsive disorder, panic disorder and healthy volunteers.
    Slaap BR; Nielen MM; Boshuisen ML; van Roon AM; den Boer JA
    J Affect Disord; 2004 Feb; 78(2):141-8. PubMed ID: 14706724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tic-related obsessive-compulsive disorder (OCD): phenomenology and treatment outcome in the Pediatric OCD Treatment Study II.
    Conelea CA; Walther MR; Freeman JB; Garcia AM; Sapyta J; Khanna M; Franklin M
    J Am Acad Child Adolesc Psychiatry; 2014 Dec; 53(12):1308-16. PubMed ID: 25457929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural Correlates of Response to Pharmacotherapy in Obsessive-Compulsive Disorder: Individualized Cortical Morphology-Based Structural Covariance.
    Yun JY; Jang JH; Kim SN; Jung WH; Kwon JS
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():126-33. PubMed ID: 26116795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caudate volume differences among treatment responders, non-responders and controls in children with obsessive-compulsive disorder.
    Vattimo EFQ; Barros VB; Requena G; Sato JR; Fatori D; Miguel EC; Shavitt RG; Hoexter MQ; Batistuzzo MC
    Eur Child Adolesc Psychiatry; 2019 Dec; 28(12):1607-1617. PubMed ID: 30972581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of trauma and post-traumatic stress disorder on the treatment response of patients with obsessive-compulsive disorder.
    Shavitt RG; Valério C; Fossaluza V; da Silva EM; Cordeiro Q; Diniz JB; Belotto-Silva C; Cordioli AV; Mari J; Miguel EC
    Eur Arch Psychiatry Clin Neurosci; 2010 Mar; 260(2):91-9. PubMed ID: 20077119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart rate and heart rate variability in obsessive-compulsive disorder: Evidence from patients and unaffected first-degree relatives.
    Jüres F; Kaufmann C; Riesel A; Grützmann R; Heinzel S; Elsner B; Bey K; Wagner M; Kathmann N; Klawohn J
    Biol Psychol; 2024 May; 189():108786. PubMed ID: 38531496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mindfulness-based cognitive therapy in obsessive-compulsive disorder: protocol of a randomized controlled trial.
    Külz AK; Landmann S; Cludius B; Hottenrott B; Rose N; Heidenreich T; Hertenstein E; Voderholzer U; Moritz S
    BMC Psychiatry; 2014 Nov; 14():314. PubMed ID: 25403813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
    Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
    JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary outcomes from the pediatric obsessive compulsive disorder treatment study II.
    Conelea CA; Selles RR; Benito KG; Walther MM; Machan JT; Garcia AM; Sapyta J; Morris S; Franklin M; Freeman JB
    J Psychiatr Res; 2017 Sep; 92():94-100. PubMed ID: 28412602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of long-term outcome in obsessive-compulsive disorder.
    Jakubovski E; Diniz JB; Valerio C; Fossaluza V; Belotto-Silva C; Gorenstein C; Miguel E; Shavitt RG
    Depress Anxiety; 2013 Aug; 30(8):763-72. PubMed ID: 23109056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How resistant is 'treatment-resistant' obsessive-compulsive disorder in youth?
    Krebs G; Isomura K; Lang K; Jassi A; Heyman I; Diamond H; Advani J; Turner C; Mataix-Cols D
    Br J Clin Psychol; 2015 Mar; 54(1):63-75. PubMed ID: 25130442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining response in clinical trials for obsessive-compulsive disorder: a signal detection analysis of the Yale-Brown obsessive compulsive scale.
    Tolin DF; Abramowitz JS; Diefenbach GJ
    J Clin Psychiatry; 2005 Dec; 66(12):1549-57. PubMed ID: 16401156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.
    Torp NC; Dahl K; Skarphedinsson G; Compton S; Thomsen PH; Weidle B; Hybel K; Valderhaug R; Melin K; Nissen JB; Ivarsson T
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):200-207.e1. PubMed ID: 25721185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining Drug and Psychological Treatments for Obsessive- Compulsive Disorder: What is the Evidence, When and for Whom.
    Albert U; Di Salvo G; Solia F; Rosso G; Maina G
    Curr Med Chem; 2018; 25(41):5632-5646. PubMed ID: 28707590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma oxytocin changes and anti-obsessive response during serotonin reuptake inhibitor treatment: a placebo controlled study.
    Humble MB; Uvnäs-Moberg K; Engström I; Bejerot S
    BMC Psychiatry; 2013 Dec; 13():344. PubMed ID: 24359174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct trajectories of long-term symptom severity in pediatric obsessive-compulsive disorder during and after stepped-care treatment.
    Jensen S; Højgaard DRMA; Hybel KA; Mortensen EL; Skarphedinsson G; Melin K; Ivarsson T; Nissen JB; Weidle B; Valderhaug R; Torp NC; Dahl K; Compton S; Thomsen PH
    J Child Psychol Psychiatry; 2020 Sep; 61(9):969-978. PubMed ID: 31736082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.